Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Exelixis, Inc. (EXEL)

« Back to company index

EXEL Chatter Timeline

Stock Ticker for EXEL

Most Active Tweeters for EXEL

UserTweets
@whatsonthorold2 14
@mmahotstuff1 14
@bulletin_en 12
@reurope_stock 9
@bibeypost_stock 9

Recent Tweets for EXEL

cfromhertz @cfromhertz
@CashRocket $EXEL needs to hold 200d MA , vpoc was taken out https://t.co/M0cwJiJfvo
April 19th 2019, 4:04pm
TheMarketsDaily @TheMarketsDaily
Exelixis $EXEL Cut to Hold at BidaskClub https://t.co/p1nGGanW8I
April 19th 2019, 3:04pm
TheMarketsDaily @TheMarketsDaily
Exelixis $EXEL Cut to Hold at BidaskClub https://t.co/WONZQY5FV2
April 19th 2019, 2:04pm
stocknewstimes @stocknewstimes
Exelixis $EXEL Lifted to “Strong-Buy” at Zacks Investment Research https://t.co/HhA3AGrCaC
April 19th 2019, 2:04pm
TranscriptDaily @TranscriptDaily
Exelixis $EXEL Lifted to “Strong-Buy” at Zacks Investment Research https://t.co/7GkWs39WqP
April 19th 2019, 2:04pm
ConsumerFeed @ConsumerFeed
Exelixis $EXEL Shares Down 6.5% https://t.co/ZK04yLquBz
April 19th 2019, 1:04pm
ZolmaxNews @ZolmaxNews
Q2 2019 Earnings Forecast for Exelixis, Inc. $EXEL Issued By William Blair https://t.co/Nh9SZX9EMC
April 19th 2019, 9:04am
AmericanBanking @AmericanBanking
Q2 2019 Earnings Forecast for Exelixis, Inc. $EXEL Issued By William Blair https://t.co/FKCCadbo41 #stocks
April 19th 2019, 9:04am
AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL Expected to Post Quarterly Sales of $215.88 Million https://t.co/UL3nenUcjO #stocks
April 19th 2019, 5:04am
mmahotstuff1 @mmahotstuff1
Exelixis INC $EXEL Share Price Rose While Penn Capital Management Co INC Has Boosted by $12.48 Million Its Position https://t.co/Qjq92IGNRz
April 18th 2019, 3:04pm
thefinreviewer @thefinreviewer
As Exelixis $EXEL Share Value Rose, Shareholder Rhenman & Partners Asset Management Ab Has Decreased by $5.75 Milli… https://t.co/XV4NNx6byA
April 18th 2019, 12:04pm
thefinreviewer @thefinreviewer
Farallon Capital Management Has Increased Stake in Exelixis $EXEL by $17.48 Million as Stock Price Rose; As Pra Gro… https://t.co/wF0KmkwPZw
April 18th 2019, 11:04am
SimTrading @SimTrading
Today's favourites for #trading : $MO, $EXEL #stockmarket #stocks #DayTrading #nasdaq #nyse #StockTrading
April 18th 2019, 10:04am
WeekHerald @WeekHerald
Exelixis $EXEL Upgraded at Zacks Investment Research https://t.co/Vc8464TobK
April 18th 2019, 10:04am
OlympiaReport @OlympiaReport
Zacks Investment Research Upgrades Exelixis $EXEL to Strong-Buy https://t.co/XsqM4Vbxhq
April 18th 2019, 10:04am
InterestRateArb @InterestRateArb
adding to $REGN small, starting $EXEL small
April 18th 2019, 9:04am
BlogYomi @BlogYomi
Capital Management Boosted Its Exelixis $EXEL Stake; Mastercard $MA Holder Ensemble Capital Management Raised Holdi… https://t.co/Yr4qSFKad1
April 18th 2019, 9:04am
AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL Receives Average Recommendation of “Buy” from Analysts https://t.co/6abDTwWgxS #stocks
April 18th 2019, 9:04am
bbnsnews @bbnsnews
Exelixis, Inc. $EXEL Given Consensus Recommendation of “Buy” by Analysts https://t.co/IQhNeDLIeu
April 18th 2019, 9:04am
AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL to Post Q1 2019 Earnings of $0.21 Per Share, William Blair Forecasts https://t.co/BPQANPnNGr #stocks
April 18th 2019, 7:04am
ZolmaxNews @ZolmaxNews
William Blair Equities Analysts Decrease Earnings Estimates for Exelixis, Inc. $EXEL https://t.co/GPR12nOOVy
April 18th 2019, 7:04am
dailypoliticaln @dailypoliticaln
Exelixis, Inc. $EXEL to Post Q1 2019 Earnings of $0.21 Per Share, William Blair Forecasts https://t.co/6R0Dl2Qjzn
April 18th 2019, 7:04am
HollyARusso @HollyARusso
@jimcramer You think $EXEL is at bottom yet?
April 18th 2019, 6:04am
BlogYomi @BlogYomi
Exelixis $EXEL Shareholder Bender Robert & Associates Has Decreased Stake as Stock Rose; Dumont & Blake Investment… https://t.co/ansTcF0lkf
April 18th 2019, 5:04am
bibeypost_stock @bibeypost_stock
EPS for Exelixis, Inc. $EXEL Expected At $0.24 https://t.co/OcXeTAlE9q
April 17th 2019, 5:04pm
studentoflife @studentoflife
RT @registrarjourn: Exelixis $EXEL Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/lllLBzLQrH
April 17th 2019, 4:04pm
ExelixisInc @ExelixisInc
$EXEL investors: We’ll announce Q1 earnings on 5/1. For more info: https://t.co/Yb0UX0lg45. https://t.co/qI9Yp7ZDDq
April 17th 2019, 4:04pm
ProTradersNews @ProTradersNews
$EXEL: Exelixis to Release First Quarter 2019 Financial Results on …: https://t.co/yjhOXHkUr2
April 17th 2019, 4:04pm
tq_equities @tq_equities
$EXEL plummets, losing $1.49 (-6.52%) within a single day: https://t.co/DqKwtydH8k Sentiment: Bearish #EXEL #Exelixis
April 17th 2019, 4:04pm
Allstocknews @Allstocknews
$EXEL Exelixis to Release First Quarter 2019 Financial Results on Wednesday, May 1, 2019 From our Stock News Alerts App
April 17th 2019, 4:04pm
BlogYomi @BlogYomi
Gemmer Asset Management Maintains Stake in Chevrontexaco $CVX; Exelixis Stk $EXEL Holder Weiss Multi-Strategy Advis… https://t.co/BJp8wk0TYz
April 17th 2019, 12:04pm
whatsonthorold2 @whatsonthorold2
Exelixis, Inc. $EXEL Can't Burn Your Short Portfolio. Has Another Weak Session https://t.co/Fnzne88syl
April 17th 2019, 12:04pm
reurope_stock @reurope_stock
Exelixis INC $EXEL Holder Trexquant Investment LP Has Trimmed Its Position by $4.56 Million https://t.co/pZ3666Q2BN
April 17th 2019, 12:04pm
registrarjourn @registrarjourn
Exelixis $EXEL Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/lllLBzLQrH
April 17th 2019, 11:04am
EnterpriseLeade @EnterpriseLeade
Exelixis $EXEL Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/B59YulOEhh
April 17th 2019, 11:04am
bbnsnews @bbnsnews
Exelixis $EXEL Cut to “Hold” at BidaskClub https://t.co/Lq4APo73aU
April 17th 2019, 10:04am
FlynancialA @FlynancialA
I strongly believe biotech bottom is in here $EXEL final test of neckline? Likely https://t.co/HvWDTk6RjY
April 17th 2019, 10:04am
bulletin_en @bulletin_en
Exelixis $EXEL Stake Held by Capital Management Corp; Royal Bank Of Scotland Group Plc Holding in Cme Group $CME Ha… https://t.co/Msmc0tJKB6
April 17th 2019, 5:04am
AmericanBanking @AmericanBanking
Brokerages Anticipate Exelixis, Inc. $EXEL Will Announce Earnings of $0.25 Per Share https://t.co/2UenSyCFsF #stocks
April 17th 2019, 4:04am
ResearchPool @ResearchPool
$EXEL #Exelixis Inc. Exelixis Cabozantinib Prospects Remain Strong Despite Increasing Competition in Oncology: No-m… https://t.co/zBfnsmqe35
April 16th 2019, 8:04pm
thefinreviewer @thefinreviewer
Phio Pharmaceuticals Corp. $EXEL Contrasting side by side https://t.co/0tldz1esE4
April 16th 2019, 7:04pm
bbnsnews @bbnsnews
Zacks Investment Research Upgrades Exelixis $EXEL to Strong-Buy https://t.co/DC2ggJ4KLH
April 16th 2019, 4:04pm
whatsonthorold2 @whatsonthorold2
Exelixis INC $EXEL Shares Rose While Rhenman & Partners Asset Management Ab Lowered Its Position https://t.co/90FhCTdYWx
April 16th 2019, 12:04pm
bibeypost_stock @bibeypost_stock
Rhenman & Partners Asset Management Ab Position in Exelixis INC $EXEL Decreased as Share Price Rose https://t.co/2AFQleLkPw
April 16th 2019, 12:04pm
whatsonthorold2 @whatsonthorold2
Is there a Bearish outlook for Exelixis, Inc. $EXEL this week? https://t.co/kHPHhFRY95
April 16th 2019, 12:04pm
ZolmaxNews @ZolmaxNews
Exelixis $EXEL Stock Rating Lowered by BidaskClub https://t.co/cVWa1wyVf5
April 16th 2019, 9:04am
ChartMill @ChartMill
Measured over the past 5 years, $EXEL shows a very strong growth in Revenue: 93.67% on average per year.… https://t.co/S38fsf3vAa
April 15th 2019, 8:04pm
mmahotstuff1 @mmahotstuff1
Exelixis, Inc. $EXEL Analysts See $0.24 EPS https://t.co/qlKpBWO29y
April 15th 2019, 4:04pm
bibeypost_stock @bibeypost_stock
Exelixis, Inc. $EXEL EPS Estimated At $0.24 https://t.co/AzLvbvdKgH
April 15th 2019, 4:04pm
bulletin_en @bulletin_en
As Exelixis $EXEL Share Price Rose, Bender Robert & Associates Cut Position by $424,555; Unitedhealth Group Com… https://t.co/84065js7BH
April 15th 2019, 1:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.